Phase I, Escalating, Multiple-Dose, ST-246 Safety, Tolerability and Pharmacokinetics 21-Day Trial in Healthy Volunteers
Completed
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 1
2007-02-01
The purpose of this study was to assess the safety, tolerability, and pharmacokinetics of a
single, daily, oral dose of ST-246 (either 250, 400 or 800mg) administered for 21 days to 30
healthy, fed volunteers.
Phase I, Escalating, Multiple-Dose, ST-246 Safety, Tolerability and Pharmacokinetics 21-Day Trial in Healthy Volunteers
Completed
SIGA Technologies
Phase 1
2007-02-01
The purpose of this study was to assess the safety, tolerability, and pharmacokinetics of a
single, daily, oral dose of ST-246 (either 250, 400 or 800mg) administered for 21 days to 30
healthy, fed volunteers.
Phase I Trial of an Investigational Small Pox Medication
Completed
National Institutes of Health (NIH)
Phase 1
2008-08-01
The purpose of this study was to evaluate the pharmacokinetic parameters and safety of a
single dose of ST-246 400mg Form I versus ST-246 400mg Form V capsules in fed normal healthy
volunteers.
Phase I Trial of an Investigational Small Pox Medication
Completed
SIGA Technologies
Phase 1
2008-08-01
The purpose of this study was to evaluate the pharmacokinetic parameters and safety of a
single dose of ST-246 400mg Form I versus ST-246 400mg Form V capsules in fed normal healthy
volunteers.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
